Ligand validation:9IJ6

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 9IJ6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9IJ6_AMP_D_401	71%	58%	0.123	0.945	0.69	0.91	-	1	1	0	100%	1
9IJ6_AMP_A_401	61%	62%	0.154	0.942	0.61	0.82	-	1	1	0	100%	1
9IJ6_AMP_C_401	53%	60%	0.161	0.922	0.74	0.78	-	1	1	0	100%	1
9IJ6_AMP_B_401	40%	62%	0.197	0.908	0.6	0.86	-	-	0	0	100%	1
8ZOZ_AMP_A_401	38%	62%	0.198	0.901	0.67	0.8	-	-	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.